Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Stefanis

Showing results (181-190 of 860) with videos related to

Pageof 86
Sort By:
Social Psychiatry and Psychiatric Epidemiology|May 11, 2004
Is the excess risk of psychosis-like experiences in urban areas attributable to altered cognitive development?N C Stefanis, Ph Delespaul, N Smyrnis, et al.
Biological Psychiatry|March 6, 2007
Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population levelNicholas C Stefanis, Thomas A Trikalinos, Dimitrios Avramopoulos, et al.
The American Journal of Psychiatry|April 1, 1979
Physical activity and plasma cyclic adenosine monophosphate levels in manic-depressive patients and healthy adultsE Lykouras, E Garelis, E Varsou, et al.
Acta Psychiatrica Scandinavica|April 1, 1993
Clinical, endocrine and neurochemical effects of moclobemide in depressed patientsB Alevizos, J Hatzimanolis, M Markianos, et al.
Psychiatry Research|May 16, 2009
Factorial composition of the Aggression Questionnaire: a multi-sample study in Greek adultsSilia Vitoratou, Ioannis Ntzoufras, Nikolaos Smyrnis, et al.
Australian Journal of General Practice|May 18, 2020
A guide to the management of paediatric pes planusClaire Turner, Matthew D Gardiner, Ann Midgley, et al.
The British Journal of Dermatology|May 17, 2021
Alopecia barbae severity score: a novel scoring system to estimate the extent of beard loss and success of treatmentA J Stefanis, P Arenberger, M Arenbergerova, et al.
Molecular and Cellular Neurosciences|October 24, 2003
Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neuronsPaula Dietrich, Hardy J Rideout, Qiaohong Wang, et al.
Current Neuropharmacology|August 18, 2023
Stress, Environment and Early PsychosisLida-Alkisti Xenaki, Stefanos Dimitrakopoulos, Mirjana Selakovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2026
Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative StudyNikolaos Papagiannakis, Christos Koros, Athina-Maria Simitsi, et al.
Pageof 86

Showing results (181-190 of 860) with videos related to

Sort By:
Pageof 86
Social Psychiatry and Psychiatric Epidemiology|May 11, 2004
Is the excess risk of psychosis-like experiences in urban areas attributable to altered cognitive development?N C Stefanis, Ph Delespaul, N Smyrnis, et al.
Biological Psychiatry|March 6, 2007
Impact of schizophrenia candidate genes on schizotypy and cognitive endophenotypes at the population levelNicholas C Stefanis, Thomas A Trikalinos, Dimitrios Avramopoulos, et al.
The American Journal of Psychiatry|April 1, 1979
Physical activity and plasma cyclic adenosine monophosphate levels in manic-depressive patients and healthy adultsE Lykouras, E Garelis, E Varsou, et al.
Acta Psychiatrica Scandinavica|April 1, 1993
Clinical, endocrine and neurochemical effects of moclobemide in depressed patientsB Alevizos, J Hatzimanolis, M Markianos, et al.
Psychiatry Research|May 16, 2009
Factorial composition of the Aggression Questionnaire: a multi-sample study in Greek adultsSilia Vitoratou, Ioannis Ntzoufras, Nikolaos Smyrnis, et al.
Australian Journal of General Practice|May 18, 2020
A guide to the management of paediatric pes planusClaire Turner, Matthew D Gardiner, Ann Midgley, et al.
The British Journal of Dermatology|May 17, 2021
Alopecia barbae severity score: a novel scoring system to estimate the extent of beard loss and success of treatmentA J Stefanis, P Arenberger, M Arenbergerova, et al.
Molecular and Cellular Neurosciences|October 24, 2003
Lack of p53 delays apoptosis, but increases ubiquitinated inclusions, in proteasomal inhibitor-treated cultured cortical neuronsPaula Dietrich, Hardy J Rideout, Qiaohong Wang, et al.
Current Neuropharmacology|August 18, 2023
Stress, Environment and Early PsychosisLida-Alkisti Xenaki, Stefanos Dimitrakopoulos, Mirjana Selakovic, et al.
Movement Disorders : Official Journal of the Movement Disorder Society|February 23, 2026
Increased Serum Neurofilament Light Chain Levels in Parkinson's Disease Patients Carrying the p.A53T SNCA Mutation: Data from the Parkinson's Progression Markers Initiative StudyNikolaos Papagiannakis, Christos Koros, Athina-Maria Simitsi, et al.
Pageof 86